Domov › Rak (vse vrste) › Alabama
Klinične študije za Rak (vse vrste) v Alabama
36 študij za Rak (vse vrste) išče udeležence na lokacijah v Alabama.
Mesta v Alabama
Uradno besedilo študije (angleško)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06989437A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- UAB Medicine - UAB Hospital, Birmingham
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 16, Birmingham
Vključevanje udeležencevFaza 3
Starost 18–71 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07504458A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063, Birmingham
- Usa Mitchell Cancer Institute /ID# 280198, Mobile
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Vključevanje udeležencevFaza 2
Starost 12 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University of Alabama Birmingham, Birmingham
Vključevanje udeležencevFaza 2/3
Vse starosti · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT03435796RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07002034A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- The University of Alabama at Birmingham ( Site 1005), Birmingham
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06818643A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Clearview Cancer Institute, Huntsville
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
Vključevanje udeležencevFaza 1
36 Months – 22 Years · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT03911388Project: Every Child for Younger Patients With Cancer
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
Vključevanje udeležencevOpazovalna študija
Do 25 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT02402244A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Childrens Hospital of Alabama, Birmingham
Vključevanje udeležencevFaza 2
Starost 1–39 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Alabama at Birmingham Cancer Center, Birmingham
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06580314Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 004, Birmingham
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 16. jul. 2026 · NCT06906341A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621, Huntsville
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT07023289A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
- University of Alabama at Birmingham, Birmingham
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT06997029A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
- University of Alabama at Birmingham, Division of Hematology and Oncology, Birmingham
Vključevanje udeležencev
Starost 60 in več · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT06697600A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, Birmingham
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 25. jun. 2026 · NCT06431594Childhood Cancer Survivor Study
- University of Alabama at Birmingham/Children's of Alabama, Birmingham
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Vse starosti · Vsi spoli · Posodobljeno 17. jun. 2026 · NCT01120353Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
Vključevanje udeležencev
Starost 18–75 · Vsi spoli · Posodobljeno 17. jun. 2026 · NCT05486572Multisite Implementation of COMPRENDO
- Children's of Alabama/University of Alabama at Birmingham, Birmingham
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT06055296Leading Healthy Eating and Activity Promotion Program
- University of Alabama at Birmingham, Birmingham
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–89 · Vsi spoli · Posodobljeno 19. maj 2026 · NCT06868524Video Inspired Discussions About Ethical Outcomes in Pediatrics
- Children's of Alabama at Birmingham, Birmingham
Vključevanje udeležencev
Vse starosti · Vsi spoli · Posodobljeno 14. maj 2026 · NCT06786104I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- University of Alabama at Birmingham, Birmingham
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT01042379Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 30. apr. 2026 · NCT05297734Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
- University of Alabama at Birmingham, Birmingham
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 24. feb. 2026 · NCT07281287TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Alabama Oncology, Birmingham
Vključevanje udeležencevOpazovalna študija
Starost 18–99 · Vsi spoli · Posodobljeno 24. feb. 2026 · NCT06207032Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
- The Kirklin Clinic, Birmingham
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 6. feb. 2026 · NCT07197515GEMINI-NSCLC: NSCLC Biomarker Study
- Alabama Oncology, Birmingham
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 5. feb. 2026 · NCT05236114Caris Biorepository Research Protocol
- University of South Alabama, Mobile
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 21. jan. 2026 · NCT01499394SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
- XCancer Research Network/Dothan Hematology & Oncology, Dothan
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 24. okt. 2025 · NCT06228326BMT-CARE: Psychosocial Intervention for Transplant Caregivers
- University of Alabama at Brimingham, Birmingham
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 15. okt. 2025 · NCT06472089Making Healthy Habits Stick
- University of Alabama at Birmingham, Birmingham
Vključevanje udeležencev
Starost 19 in več · Ženske · Posodobljeno 1. okt. 2025 · NCT06745180Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of South Alabama Mitchell Cancer Institute, Mobile
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 27. nov. 2024 · NCT03860883Collection and Distribution of Biospecimens for Novel Research Uses
- iSpecimen, Huntsville
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
1 Month – 89 Years · Vsi spoli · Posodobljeno 9. nov. 2022 · NCT03848962Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.